Skip to main content

Table 5 Antimicrobial susceptibility patterns of Gram-positive bacterial isolates from wound swab cultures among dog bite patients reporting to two DBW care centers in Uganda in the period April 2019–October 2019

From: The potential for the double risk of rabies and antimicrobial resistance in a high rabies endemic setting: detection of antibiotic resistance in bacterial isolates from infected dog bite wounds in Uganda

Bacterial isolates

Number of isolates that are resistant to antimicrobial agent, n (%)

CRO

ME

CN

AML

SXT

VA

CIP

IPM

S

DOX

OX

C

MET

Staphylococcus

S. aureus (n = 103)

0 (0.0)

103 (100)

0 (0.0)

19 (18.5)

9 (8.7)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

14 (13.6)

94 (91.3)

0 (0.0)

0 (0.0)

S. intermedius (n = 30)

0 (0.0)

30 (100)

0 (0.0)

12 (40.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

28 (93.3)

15 (50.0)

0 (0.0)

CONS (n = 68)

7 (10.3)

66 (97.1)

0 (0.0)

21 (30.9)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

8 (11.8)

61 (89.7)

0 (0.0)

0 (0.0)

Streptococuss

S. canis (n = 18)

6 (33.3)

18 (100)

2 (11.1)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

8 (44.4)

18 (100)

4 (22.2)

0 (0.0)

0 (0.0)

S. pyogenes (n = 29)

12 (41.4)

21 (72.4)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

3 (10.3)

0 (0.0)

0 (0.0)

8 (27.6)

0 (0.0)

0 (0.0)

Other Streptococci (n = 12)

3 (25.0)

8 (66.7)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

2 (16.7)

0 (0.0)

0 (0.0)

Bacillus spp (n = 11)

4 (36.4)

11 (100)

3 (27.3)

1 ((9.1)

4 (36.4)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

3 (27.3)

2 (18.1)

0 (0.0)

Enterococcus

E. feacalis (n = 19)

11 (58.9)

19 (100)

5 (26.3)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

4 (21.1)

3 (15.8)

0 (0.0)

9 (47.4)

7 (36.8)

12 (63.2)

E. faecium (n = 2)

1 (50.0)

2 (100)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (50.0)

1 (50.0)

0 (0.0)

0 (0.0)

Other Enterococci (n = 6)

0 (0.0)

6 (100)

1 (16.7)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (16.7)

0 (0.0)

2 (33.3)

0 (0.0)

0 (0.0)

Micrococcus spp (n = 8)

0 (0.0)

8 (100)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Corynebacterium spp (n = 33)

0 (0.0)

33 (100)

9 (27.3)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

12 (36.4)

0 (0.0)

0 (0.0)

Gemella morbillorum (n = 21)

0 (0.0)

21 (100)

1 (4.8)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

2 (9.5)

0 (0.0)

18 (85.7)

0 (0.0)

0 (0.0)

Lactobacillus spp (n = 31)

8 (25.8)

26 (83.9)

5 (16.1)

4 (12.9)

0 (0.0)

0 (0.0)

0 (0.0)

8 (25.8)

7 (22.6)

6 (19.4)

26 (100)

8 (25.8)

0 (0.0)

Lactococcus spp (n = 15)

8 (53.3)

8 (53.3)

3 (20.0)

0 (0.0)

3 (20.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

4 (26.7)

10 (66.7)

4 (26.7)

2 (13.3)

Total isolates N = 406

60 (14.8)

380 (93.6)

29 (7.1)

57 (14.0)

16 (3.9)

0 (0.0)

0 (0.0)

15 (3.7)

21 (5.2)

51 (12.6)

278 (68.5)

36 (8.9)

14 (3.5)

  1. CRO ceftriaxone; ME metronidazole; CN gentamycin; AML amoxicillin / clavulanic acid; SXT trimethoprim / sulfamethoxazole; VA vancomycin; CIP ciprofloxacin; IPM imipenem; S streptomycin; DOX doxycycline; OX oxacillin; C chloramphenicol; MET methicillin
  2. The antimicrobial susceptibility patterns of the Gram-positive bacterial isolates. Among the gram positive isolates, the most frequent, S. aureus, exhibited high resistance to metronidazole (103, 100%) and oxacillin (94, 91.3%) while the resistance to amoxicillin, doxycycline and trimethoprim / sulfamethoxazole was considerably lower at 19 (18.5%), 14 (13.6%) and 9 (8.7%), respectively